Subcutaneous advanced glycation end-products and lung function according to glucose abnormalities: The ILERVAS Project
- 13 April 2018
- journal article
- letter
- Published by Elsevier in Diabetes & Metabolism
- Vol. 45 (6) , 595-598
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Pulmonary Function and Sleep Breathing: Two New Targets for Type 2 Diabetes CareEndocrine Reviews, 2017
- Skin autofluorescence, renal insufficiency and retinopathy in patients with type 2 diabetesJournal of Diabetes and its Complications, 2017
- Advanced Glycation End Products: Association with the Pathogenesis of Diseases and the Current Therapeutic AdvancesCurrent Clinical Pharmacology, 2016
- Estudio de intervención aleatorizado para evaluar la prevalencia de enfermedad ateromatosa y renal ocultas y su impacto en la morbimortalidad: Proyecto ILERVASNefrología, 2016
- Advanced glycation endproducts and their receptor in different body compartments in COPDRespiratory Research, 2016
- Lifestyle and clinical determinants of skin autofluorescence in a population‐based cohort studyEuropean Journal of Clinical Investigation, 2016
- Receptor for advanced glycation end products expressed on alveolar epithelial cells is the main target for hyperoxia-induced lung injuryRespiratory Investigation, 2016
- Advanced glycation end products in the skin are enhanced in COPDMetabolism, 2014
- Pulmonary Function in DiabetesChest, 2010